Incannex Healthcare Inc
For the period ended Mar 31, 2024. Filed May 15, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 15, 2024
IXHL$2.01-8.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations and Comprehensive Loss
| For the three months ended March 31, | For the nine months ended March 31, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Operating expenses: | ||||
| Research and development | $3,277 | $1,639 | $8,520 | $4,597 |
| Acquisition of in-process research and development | - | - | - | 35,347 |
| General and administrative | 4,138 | 2,012 | 11,777 | 5,530 |
| Total operating expenses | $7,415 | $3,651 | $20,297 | $45,474 |
| Loss from operations | (7,415) | (3,651) | (20,297) | (45,474) |
| Other income/(expense), net: | - | - | - | - |
| R&D tax incentive | 1,320 | (83) | 8,150 | 684 |
| Foreign exchange expense | (11) | - | (17) | - |
| Interest income | 75 | 163 | 166 | 153 |
| Total other income, net | $1,384 | $80 | $8,299 | $837 |
| Loss before income tax expense | (6,031) | (3,571) | (11,998) | (44,637) |
| Income tax expense | - | - | - | - |
| Net loss | $(6,031) | $(3,571) | $(11,998) | $(44,637) |
| Other comprehensive loss: | ||||
| Currency translation adjustment, net of tax | (820) | (202) | (403) | (2,029) |
| Total comprehensive loss | $(6,851) | $(3,773) | $(12,401) | $(46,666) |
| Net loss per share: Basic and diluted | $(0.38) | $(0.22) | $(0.76) | $(2.93) |
| Weighted average number of shares outstanding, basic and diluted | 15,873,113 | 15,873,113 | 15,873,113 | 15,221,900 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.